<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Supernus Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company currently markets Trokendi XRÂŽ (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, and Oxtellar XRÂŽ (extended-release oxcarbazepine) for the treatment of epilepsy. The Company is also developing several product candidates to address large market opportunities in the CNS market, including SPN-810 for the treatment of Impulsive Aggression in ADHD patients, SPN-812 for the treatment of ADHD and SPN-604 for the treatment of bipolar disorder. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jack A. Khattar
    • FOUNDED
      2005
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Akero Therapeutics, Inc.

    Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high...

    Akero aims to develop and deliver transformatio...

    Filing Type:    PU
    Vertex Pharmaceuticals Incorporated

    Vertex Pharmaceuticals Incorporated

    Vertex is a global biotechnology company that invests in scientific innovation to ...

    Vertex is a global biotechnology company that i...

    Filing Type:    PU
    Citizen Health Project, Inc.

    Citizen Health Project, Inc.

    Citizen Health is a public benefit company rebuilding healthcare on an open & tran...

    Citizen Health is a public benefit company rebu...

    Amount Raised:    $122,087
    Fundraising Status:    EC
    Filing Type:    CF
    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...

    Concert Pharmaceuticals is a clinical stage bio...

    Filing Type:    PU
    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing comme...

    BioDelivery Sciences International, Inc. (NASDA...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Alkermes plc

    Alkermes plc

    Alkermes plc is a fully integrated, global biopharmaceutical company developing in...

    Alkermes plc is a fully integrated, global biop...

    Filing Type:    PU
    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused o...

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a r...

    Filing Type:    PU
    Trevena, Inc.

    Trevena, Inc.

    Trevena is a biopharmaceutical company focused on the development and commercializ...

    Trevena is a biopharmaceutical company focused ...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.